|
?:authorAffiliation
|
-
[\'Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, Maryland, USA, 20993.\', \'Center for Vaccines and Immunology, University of Georgia, Athens, Georgia, USA, 30602.\', \'Center for Vaccines and Immunology, University of Georgia, Athens, Georgia, USA, 30602; Department of Infectious Diseases, University of Georgia, Athens, Georgia, USA, 30602.\', \'Division of Viral Products, Center for Biologics Evaluation and Research (CBER), FDA, Silver Spring, Maryland, USA, 20993. Electronic address: Surender.Khurana@fda.hhs.gov.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}